Trials / Conditions / DEB - Dystrophic Epidermolysis Bullosa
DEB - Dystrophic Epidermolysis Bullosa
3 registered clinical trials studyying DEB - Dystrophic Epidermolysis Bullosa — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa NCT07016750 | Krystal Biotech, Inc. | Phase 3 |
| Completed | A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa NCT04917874 | Krystal Biotech, Inc. | Phase 3 |
| Withdrawn | The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB) NCT04214002 | Krystal Biotech, Inc. | — |